1. Home
  2. RTO vs RDY Comparison

RTO vs RDY Comparison

Compare RTO & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rentokil Initial plc

RTO

Rentokil Initial plc

HOLD

Current Price

$28.49

Market Cap

13.7B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.19

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RTO
RDY
Founded
1925
1984
Country
United Kingdom
India
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7B
11.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RTO
RDY
Price
$28.49
$14.19
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
N/A
$16.90
AVG Volume (30 Days)
812.9K
938.9K
Earning Date
01-21-2026
01-22-2026
Dividend Yield
1.79%
0.50%
EPS Growth
N/A
9.95
EPS
0.13
0.79
Revenue
$7,581,860,530.00
$3,851,623,984.00
Revenue This Year
$48.64
$6.16
Revenue Next Year
$3.22
$2.57
P/E Ratio
$42.11
$17.87
Revenue Growth
N/A
14.10
52 Week Low
$19.60
$12.26
52 Week High
$30.10
$16.17

Technical Indicators

Market Signals
Indicator
RTO
RDY
Relative Strength Index (RSI) 64.06 57.67
Support Level $27.47 $13.64
Resistance Level $28.65 $14.20
Average True Range (ATR) 0.38 0.16
MACD 0.18 0.05
Stochastic Oscillator 92.15 98.25

Price Performance

Historical Comparison
RTO
RDY

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: